INNOVAX® ND-IBD

Innovax®-ND-IBD is a frozen, live, cell-associated vaccine against Newcastle disease (ND), infectious bursal disease (IBD) and Marek’s disease (MD).

Product Description

Advantages:

  • First dual construct vaccine which provides unique 3-in-1 protection, very convenient for application.
  • Does not interfered by MDA of ND and IBD.
  • Provide protection as good as conventional MD, ND, and IBD vaccines.
  • Early immune response, life-long disease prevention.

Indications:

Innovax®-ND-IBD is recommended for vaccination of healthy 18-day-old chicken embryos by in-ovo route or of one-day-old chickens by the subcutaneous route to aid in the prevention against Marek’s disease, Newcastle disease and infectious bursal disease.

Content:

Cell-associated live recombinant HVT strain HVP 360, expressing the F (fusion) protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus   103.3 – 104.6 PFU.

Dosing and Administration:

Vaccination was given by in-ovo route at a dose of 0.05 ml per injection in 18-day-old chicken embryos or in one-day-old chicks via subcutaneous injection at a dose of 0.2 ml per injection. Use Nobilis® Diluent CA for reconstitution.

Presentation:

1000, 2000, 3000, 4000 or 5000 doses.

Storage:

Ampoules – store in a filled liquid nitrogen container.

Diluent – store at room temperature (15°C– 25°C).

Container – store liquid nitrogen container securely in upright position in a clean, dry, and well-ventilated room separated from the hatching / chicken room in the hatchery.

Registration holder:

PT Intervet Indonesia

(Product under registration)

For animal use only.
Not all presentations may be marketed.
For more information, please visit our dedicated website.

Combination active vaccine against infectious bronchitis (IB) and Newcastle disease (ND).

Active vaccine against infectious bronchitis (IB) in poultry.